Products

LumiNE US
Augmedit B.V.
Neurology AI
LumiNE US by Augmedit B.V. is an AI-powered augmented reality software that transforms 2D MRI and CT scans into 3D models for enhanced neurosurgical planning and visualization.

See all 1 product →

About Augmedit B.V.

Augmedit B.V. is a medical software company specializing in Augmented Reality (AR) and Extended Reality (XR) solutions designed to enhance surgical precision, planning, and education. Their core offering involves transforming 2D medical imaging, such as CT and MRI scans, into interactive 3D holograms. This technology aims to provide surgeons with a more intuitive and comprehensive understanding of patient anatomy and pathology, thereby improving surgical outcomes and operational efficiency.

The company’s product suite includes Lumi™ software, which facilitates the conversion of DICOM images into 3D volume models and holograms for surgical preparation and patient education. LumiNE Lite specifically supports neurosurgical planning by automatically segmenting relevant anatomical structures from head scans. Their advanced LumiNE Elite module is designed for intra-operative use, projecting these precise holograms onto the patient to guide surgeons in real-time during procedures. This holographic guidance is intended to reduce errors, improve decision-making, and lead to safer surgeries while also offering significant cost savings for healthcare institutions.

Augmedit is actively expanding its market reach, pursuing FDA clearance for its products in the United States, and broadening its application beyond neurosurgery to include maxillofacial, orthopedic, and oncology fields. Their solutions are designed to integrate seamlessly into existing surgical workflows, offering hardware-agnostic compatibility and a low-priced subscription model. By making complex anatomical data more accessible and interactive, Augmedit aims to revolutionize surgical practice, improve individualized treatment planning, and enhance communication between medical staff and patients.

Focus Areas

Augmented Reality Artificial Intelligence surgical planning neurosurgery patient education medical training 3D visualization oral and maxillofacial surgery

Business Intelligence

Key InvestorsRevere Partners, Dutch and Swiss informal investors, EIC Accelerator, EIC Fund, Eurostars, Great Stuff Ventures, Egeria Impact Investments
PartnershipsUMC Utrecht, University Hospital Zurich (USZ Zurich), Disior Oy, Amsterdam UMC
TechnologyCloud-native, AI algorithms for semi-automatic segmentation, Augmented Reality (AR), Extended Reality (XR), Microsoft HoloLens 2 compatible
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Augmented Reality (AR) & 3D Visualization
Augmedit specializes in converting 2D medical images (MRI, CT) into interactive 3D holograms for both pre-operative planning and real-time intra-operative guidance. Their AR solutions provide immersive visualization of patient data via wireless Head-Mounted Displays (HMDs).
Artificial Intelligence (AI) for Segmentation
They leverage AI-based algorithms for automatic and semi-automatic segmentation of critical anatomical structures, such as tumors, brain structures, skin, and ventricles, from medical scans. This AI-driven approach enhances surgical precision and provides accelerated insights.
Surgical Planning & Neurosurgery Focus
Augmedit's Lumi and LumiNE Lite software enable surgeons to efficiently prepare individualized treatment plans by converting DICOM images into 3D volume models and holograms. They have a strong initial focus on neurosurgery, with products like LumiNE US receiving FDA clearance for neurosurgical planning and LumiNE Elite for intra-operative neurosurgical visualization under development.
Patient Education & Shared Decision Making
The patient-specific 3D holograms significantly enhance patient understanding and engagement, fostering improved communication between patients and clinicians regarding their medical conditions and treatment options.
Medical Training & Workflow Enrichment
Augmedit aims to train medical staff using their AR solutions and provides an intuitive AR workflow that enriches existing surgical procedures, potentially shortening preparation and surgery times.
Oral and Maxillofacial Surgery Expansion
While initially focused on neurosurgery, Augmedit plans to expand its technology to other high-volume, high-impact surgical specialties, including oral and maxillofacial surgery.
Physician Tip

Augmedit's solutions offer physicians enhanced surgical precision and improved patient outcomes through real-time AR guidance and 3D visualization, effectively providing 'X-ray vision' without actual X-rays. The AI-powered automatic segmentation streamlines pre-operative planning and provides deeper insights, leading to better decision-making and reduced preventable errors. The intuitive, cloud-based workflow integrates seamlessly into existing practices, and the patient-specific holograms significantly improve patient engagement and communication, fostering shared decision-making.

Augmedit's platform is purely cloud-based and hardware-agnostic, designed to be compatible with devices like Microsoft HoloLens 2, web, and mobile (coming soon). This approach eliminates the need for hospitals to purchase expensive capital equipment, offering a low-priced subscription model. The system converts standard DICOM images (MRI, CT) into 3D models and utilizes AI algorithms for segmentation, indicating a focus on interoperability with existing medical imaging infrastructure. Their technology stack includes Python, C++, and Docker for algorithm development and cloud solutions.

Products by Augmedit B.V.

1 product in the directory

LumiNE US
Augmedit B.V.
Neurology AI
LumiNE US by Augmedit B.V. is an AI-powered augmented reality software that transforms 2D MRI and CT scans into 3D models for enhanced neurosurgical planning and visualization.

What the Web Says

Augmedit B.V. appears to be a company focused on medical technology, specifically augmented reality solutions for surgical planning and execution. While direct product reviews on major platforms like G2, Capterra, and Reddit are scarce, the company's LinkedIn profile and general industry discussions suggest a positive outlook on their innovative approach to healthcare. Employer reviews are also not readily available on Glassdoor.

Overall: Mixed

Strengths

  • Innovative use of augmented reality in healthcare
  • Potential to improve surgical precision and outcomes
  • Focus on cutting-edge medical technology
  • Likely to attract top talent in AR/VR and medical fields
  • Addresses a critical need in surgical planning

Limitations

  • Limited public reviews and opinions available
  • Lack of readily accessible product reviews on major platforms (G2, Capterra)
  • No employer reviews found on Glassdoor
  • Adoption in healthcare can be slow due to regulatory hurdles
  • High cost of implementation for AR solutions

Based on reviews from: G2 (no specific reviews found), Glassdoor (no specific reviews found), Capterra (no specific reviews found), Reddit (no specific reviews found), LinkedIn (company profile, general industry sentiment)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Augmedit B.V..

Loading videos...

Videos load interactively. If none appear, search YouTube for Augmedit B.V. →

View all on YouTube

Press & Coverage

UMC Utrecht
First brain surgeries performed using holograms - UMC Utrecht's research
UMC Utrecht and its spin-off Augmedit have successfully performed the first brain surgeries using AI-converted holograms from MRI/CT scans, projected onto the patient's head with 3D glasses for real-time guidance. This technology, which has received CE certification, aims to fundamentally change surgical preparation and execution, improving safety and accuracy.
2026-01
Augmedit
Launch Announcement: LumiNE Elite Achieves CE Approval
Augmedit announced that its LumiNE Elite software has achieved CE approval, signifying its official certification for use in patients across Europe and compliance with European safety and effectiveness requirements.
2026-01
Augmedit
Augmedit Announces First Closing of Series A Round Led by Egeria Impact Investments, Joined by EIC Fund
Augmedit announced the first closing of its Series A funding round, led by Egeria Impact Investments and joined by the EIC Fund. This funding will be used to scale up the company, with an expected headcount of 160 by 2028.
2025-06
J Med Syst.
Development and Validation of a Neurosurgical Phantom for Simulating External Ventricular Drain Placement
This peer-reviewed article details the development and validation of a neurosurgical phantom designed for simulating external ventricular drain placement, a crucial step in preparing for clinical validation of Augmedit's LumiNE Elite software.
2025-01
Augmedit
LumiNE US Software Receives FDA Clearance for Surgical Planning
Augmedit's LumiNE US software received FDA clearance for surgical planning, allowing medical professionals to convert 2D patient imaging into 3D models for enhanced visualization during surgical preparation. The software integrates Augmented Reality (AR) and Artificial Intelligence (AI) to revolutionize medical imaging use in clinical environments.
2024-09
Augmedit
Feature on Dutch National TV
Augmedit's Lumi software was showcased on Dutch National TV program Eenvandaag, highlighting its innovative application in medical augmented reality.
2024-04
Augmedit
Augmedit Closes Seed Investment Round
Augmedit, a Dutch startup developing Augmented Reality software for surgeons, closed a seed investment round of over u20ac1M with Dutch and Swiss investors and US-based Revere Partners, along with u20ac1.7M non-dilutive funding from the EIC Accelerator program.
2022-11
Augmedit
Augmedit secures a u20ac1.7 million grant from the European Innovation Council (EIC) Accelerator Program
Augmedit was awarded a u20ac1.7 million grant from the European Innovation Council (EIC) Accelerator Program to finalize LumiNE Elite developments, CE certify the software, and accelerate sales of LumiNE light for surgical preparation and patient education.
2022-10

Frequently Asked Questions

Augmedit B.V. offers the Lumiu2122 software, which is CE certified and automatically generates 3D holograms from medical imaging for surgical preparation and patient education. Their LumiNE Lite software specifically aids neurosurgical planning by converting head scans into 3D models and using AI for automatic segmentation of anatomical structures. The upcoming LumiNE Elite product will project these holograms directly onto the patient in the operating room for intra-operative guidance, while their FDA-cleared LumiNE US software provides similar AR and AI-driven capabilities for surgical planning in the US market.
Augmedit B.V.'s initial focus and beachhead products are designed for neurosurgeons, with their LumiNE Lite and LumiNE US software specifically supporting neurosurgical planning. The company is actively expanding its technology to high-volume, high-impact indications beyond neurosurgery, including oral and maxillofacial surgery. They have successfully performed initial brain surgeries using their holographic guidance and plan to introduce their first maxillofacial product to the market within the next 6 to 18 months.
Augmedit B.V. has achieved CE certification for its Lumiu2122 software and LumiNE Lite software (Class 1 MDD), allowing their use in Europe. Furthermore, their LumiNE US software received FDA clearance for surgical planning in September 2024, enabling its deployment in the United States. The intra-operative holographic guidance technology used in recent brain surgeries has also received CE certification.
Augmedit's mission includes visually engaging and educating patients and their families, as well as providing tools for medical staff training. Their Lumiu2122 software generates patient-specific 3D holograms that enhance patient understanding and engagement, improving patient-clinician communication. This holographic experience also offers immersive medical training opportunities, enriching existing surgical workflows and accelerating insights for medical professionals.
Augmedit B.V. operates on a low-priced subscription model, eliminating the need for hospitals to purchase expensive capital equipment. Their software is hardware agnostic, compatible with devices like the Microsoft HoloLens 2, and will soon support web and mobile platforms. While specific support details are not extensively publicized, their team includes a Clinical Implementation Specialist, suggesting dedicated assistance for integrating their technology into clinical workflows.
Founded in 2018, Augmedit B.V. has demonstrated stability through a seed investment round of over u20ac1M in November 2022 and an additional u20ac1.7M non-dilutive funding from the EIC Accelerator program. The company is actively growing, with a total funding of $2.68M over two rounds as of April 2026, and is currently seeking to raise u20ac7 million in a Series A round. Key partnerships include US-based venture capital fund Revere Partners, a Eurostars grant collaboration with Disior Oy, and strong ties with academic centers like UMC Utrecht and USZ Zurich, with clinical traction in 10 centers across 5 countries.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.